ClinicalTrials.gov
ClinicalTrials.gov Menu

Crossed Leg Sign and it's Correlation With Significant Pathology

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01569542
Recruitment Status : Unknown
Verified March 2012 by Uelk, J. Daniel, D.O..
Recruitment status was:  Not yet recruiting
First Posted : April 3, 2012
Last Update Posted : April 3, 2012
Sponsor:
Information provided by (Responsible Party):
Uelk, J. Daniel, D.O.

Study Description
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
By determining the correlation of a Crossed Leg Sign with significant pathology, a clinician would then be able to use this correlation to risk stratify his/her patients for significant pathology.

Condition or disease
Pathology

Detailed Description:
By determining the correlation of a Crossed Leg Sign with significant pathology, a clinician would then be able to use this correlation to risk stratify his/her patients for significant pathology. Therefore, by determining the sensitivity and specificity of this physical exam finding, the clinician would have a better idea of the patients clinical management, including diagnostic testing and ultimate treatment of the patient. Crossed Leg Sign will be defined in this study as: any patient observed in the Emergency Department with sustained crossed legs. To my knowledge, crossed legs have never been evaluated in regards to it's correlation with significant pathology. This could potentially add another physical exam finding to be used by the clinician.

Study Design
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Observational
Estimated Enrollment : 400 participants
Observational Model: Case Control
Time Perspective: Prospective
Official Title: Crossed Leg Sign and it's Correlation With Significant Pathology
Study Start Date : May 2012
Estimated Primary Completion Date : February 2013
Estimated Study Completion Date : February 2013
Groups and Cohorts
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Eligibility Criteria
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
This study should include all comers. To exclude a patient population would add a selection bias.
Criteria

Inclusion Criteria:

  • Any patient observed in the Emergency Department with sustained crossed legs.

Exclusion Criteria:

  • Any patient not observed to have sustained crossed legs and is not being used as a control.
Contacts and Locations
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01569542


Contacts
Contact: John D Uelk, DO 314-605-4486 juelk1@hfhs.org
Contact: Michael Ward, DO 908-930-2405 mward4@hfhs.org

Locations
United States, Michigan
Henry Ford Wyandotte Hospital Not yet recruiting
Wyandotte, Michigan, United States, 48192
Contact: John D Uelk, DO    314-605-4486    juelk1@hfhs.org   
Principal Investigator: John D Uelk, DO         
Sponsors and Collaborators
Uelk, J. Daniel, D.O.
Investigators
Principal Investigator: John D Uelk, DO Henry Ford Health System
More Information
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party: Uelk, J. Daniel, D.O.
ClinicalTrials.gov Identifier: NCT01569542     History of Changes
Other Study ID Numbers: John Daniel Uelk
Henry Ford Wyandotte Hospital ( Other Identifier: Henry Ford Wyandotte Hospital )
First Posted: April 3, 2012    Key Record Dates
Last Update Posted: April 3, 2012
Last Verified: March 2012